PanThera
Biopharma Technology
PanThera
leverages proprietary technologies and enabling capabilities
in structure-based drug design, medicinal chemistry and high
throughput screening to discover and develop safe and effective
small molecule drugs against life-threatening diseases.
Our
drug discovery strategy encompasses tools and expertise that
can be applied to multiple pathogens, thereby improving the
efficiency and speed of the discovery process. PanThera’s
small molecule drug discovery platform, funded in part by
NIH grants, is addressing important biodefense and emerging
infectious disease targets, such as anthrax, botulinum toxin,
dengue fever and West Nile virus.
